Ncs Pharmaceuticals - NJ Somerset, Somerset 08873

Ncs Pharmaceuticals entered the industry of Industry Specialist Consultants in 2007 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541611, which describes it as a Industry Specialist Consultants. For further clarification, the SIC classifies this business under the code 8742 and described it as a Industry Specialist Consultants. The business provides service to the B2B market.

To acquire more information, please contact Clint Streit by calling (732) 805-9977 during business hours. You can also write to the business’ Single Location at 2 Executive Drive # 100, Somerset, New Jersey NJ 08873. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Ncs Pharmaceuticals
Representative: Clint Streit
Place of Business: 2 Executive Drive # 100, Somerset, NJ 08873
Contact Number: (732) 805-9977
Type of Service: Industry Specialist Consultants
SIC Number: 8742
NAICS Number: 541611
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2007
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Ncs Pharmaceuticals is a company operating from Somerset, New Jersey providing professional Industry Specialist Consultants and relevant B2B variables. It was founded in 2007 and registered with the SIC code 8742 as Industry Specialist Consultants, and with the NAICS code 541611 as Industry Specialist Consultants.

With a current employee count of 1 to 4, Ncs Pharmaceuticals has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Clint Streit at (732) 805-9977 for related queries, or to locate its Single Location using the coordinates .

The Single Location can also be found at the street address 2 Executive Drive # 100 in Somerset, New Jersey 08873 and can be engaged online through the company website at , the company Twitter , and Facebook page .